Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer metabolism

Methionine and H2S alter cancer–immune dialogue

Methionine restriction modulates tumour growth and ageing processes through its influence on diverse metabolic processes. Ji et al. demonstrate that methionine restriction compromises production of hydrogen sulfide (H2S), which impairs H2S-mediated immune signalling and results in increased cancer progression in immunocompetent mice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The effect of methionine restriction differs according to immunocompromised versus immunocompetent status.

References

  1. Wang, T. J. et al. Nat. Med. 17, 448–453 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Handzlik, M. K. et al. Nature 614, 118–124 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ren, B. et al. Redox Biol. 41, 101940 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bárcena, C. et al. Cell Rep. 24, 2392–2403 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tönjes, M. et al. Nat. Med. 19, 901–908 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Krall, A. S., Xu, S., Graeber, T. G., Braas, D. & Christofk, H. R. Nat. Commun. 7, 11457 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ji, M. et al. Nat. Metab. https://doi.org/10.1038/s42255-023-00854-3 (2023).

    Article  PubMed  Google Scholar 

  8. Gao, X. et al. Nature 572, 397–401 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Miller, T. W. et al. J. Biol. Chem. 287, 4211–4221 (2012).

    Article  CAS  PubMed  Google Scholar 

  10. Papapetropoulos, A. et al. Proc. Natl Acad. Sci. USA 106, 21972–21977 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Sen, N. et al. Mol. Cell 45, 13–24 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ma, E. H. et al. Cell Metab. 25, 345–357 (2017).

    Article  CAS  PubMed  Google Scholar 

  13. Roy, D. G. et al. Cell Metab. 31, 250–266.e9 (2020).

    Article  CAS  PubMed  Google Scholar 

  14. Gensollen, T., Iyer, S. S., Kasper, D. L. & Blumberg, R. S. Science 352, 539–544 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Li, T. et al. Gut 72, 501–511 (2023).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian M. Metallo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joulia, E., Metallo, C.M. Methionine and H2S alter cancer–immune dialogue. Nat Metab 5, 1456–1458 (2023). https://doi.org/10.1038/s42255-023-00862-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-023-00862-3

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer